Lpl Financial LLC Crispr Therapeutics Ag Call Options Transaction History

Lpl Financial LLC

  • $320 Billion
  • Q3 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$48.51 - $68.14 $38,808 - $54,512
-800 Reduced 12.12%
5,800 $375,000
Q2 2025

Aug 12, 2025
BUY
$31.27 - $48.64 $3,127 - $4,864
100 Added 1.54%
6,600 $321,000
Q1 2025

May 07, 2025
BUY
$34.03 - $53.02 $221,195 - $344,630
6,500 New
6,500 $221,000

Others Institutions Holding CRSP

# of Institutions
546
Shares Held
67.7M
Call Options Held
3.5M
Put Options Held
3.08M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.32B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email